Annual Current Assets
$147.81 M
-$33.21 M-18.35%
December 31, 2023
Summary
- As of February 12, 2025, ALDX annual total current assets is $147.81 million, with the most recent change of -$33.21 million (-18.35%) on December 31, 2023.
- During the last 3 years, ALDX annual current assets has risen by +$64.75 million (+77.96%).
- ALDX annual current assets is now -36.49% below its all-time high of $232.75 million, reached on December 31, 2021.
Performance
ALDX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$116.72 M
-$8.93 M-7.11%
September 30, 2024
Summary
- As of February 12, 2025, ALDX quarterly total current assets is $116.72 million, with the most recent change of -$8.93 million (-7.11%) on September 30, 2024.
- Over the past year, ALDX quarterly current assets has dropped by -$30.49 million (-20.71%).
- ALDX quarterly current assets is now -54.45% below its all-time high of $256.26 million, reached on June 30, 2021.
Performance
ALDX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ALDX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.4% | -20.7% |
3 y3 years | +78.0% | -52.7% |
5 y5 years | +56.0% | +51.5% |
ALDX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -36.5% | at low | -49.9% | at low |
5 y | 5-year | -36.5% | +96.6% | -54.5% | +86.0% |
alltime | all time | -36.5% | >+9999.0% | -54.5% | +5803.9% |
Aldeyra Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $116.72 M(-7.1%) |
Jun 2024 | - | $125.65 M(-10.8%) |
Mar 2024 | - | $140.85 M(-4.7%) |
Dec 2023 | $516.60 K(+92.4%) | $147.81 M(+0.4%) |
Sep 2023 | - | $147.21 M(-5.3%) |
Jun 2023 | - | $155.48 M(-7.5%) |
Mar 2023 | - | $168.02 M(-7.2%) |
Dec 2022 | $268.50 K(-30.2%) | $181.02 M(-4.5%) |
Sep 2022 | - | $189.48 M(-5.6%) |
Jun 2022 | - | $200.74 M(-9.7%) |
Mar 2022 | - | $222.36 M(-4.5%) |
Dec 2021 | $384.40 K(+31.1%) | $232.75 M(-5.7%) |
Sep 2021 | - | $246.77 M(-3.7%) |
Jun 2021 | - | $256.26 M(+74.2%) |
Mar 2021 | - | $147.07 M(+77.1%) |
Dec 2020 | $293.20 K(-16.1%) | $83.06 M(-5.8%) |
Sep 2020 | - | $88.19 M(+23.5%) |
Jun 2020 | - | $71.42 M(+13.8%) |
Mar 2020 | - | $62.75 M(-16.5%) |
Dec 2019 | $349.50 K(+8.6%) | $75.17 M(-2.4%) |
Sep 2019 | - | $77.02 M(+5.7%) |
Jun 2019 | - | $72.86 M(-16.3%) |
Mar 2019 | - | $87.00 M(-8.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2018 | $321.90 K(+53.9%) | $94.77 M(+157.2%) |
Sep 2018 | - | $36.85 M(-14.5%) |
Jun 2018 | - | $43.07 M(+6.1%) |
Mar 2018 | - | $40.60 M(-7.6%) |
Dec 2017 | $209.20 K(+270.9%) | $43.97 M(-10.4%) |
Sep 2017 | - | $49.05 M(+86.2%) |
Jun 2017 | - | $26.34 M(-16.3%) |
Mar 2017 | - | $31.47 M(+25.2%) |
Dec 2016 | $56.40 K(-51.6%) | $25.13 M(-13.7%) |
Sep 2016 | - | $29.13 M(-11.2%) |
Jun 2016 | - | $32.81 M(+40.8%) |
Mar 2016 | - | $23.31 M(-17.0%) |
Dec 2015 | $116.60 K(+328.7%) | $28.09 M(-10.0%) |
Sep 2015 | - | $31.23 M(-7.7%) |
Jun 2015 | - | $33.84 M(+112.8%) |
Mar 2015 | - | $15.90 M(+81.5%) |
Dec 2014 | $27.20 K(-94.2%) | $8.76 M(-15.3%) |
Sep 2014 | - | $10.34 M(-12.4%) |
Jun 2014 | - | $11.81 M(+447.7%) |
Mar 2014 | - | $2.16 M(-34.1%) |
Dec 2013 | $472.50 K(>+9900.0%) | $3.27 M(+18.1%) |
Sep 2013 | - | $2.77 M(+40.1%) |
Dec 2012 | $0.00(-100.0%) | $1.98 M |
Dec 2011 | $3700.00 | - |
FAQ
- What is Aldeyra Therapeutics annual total current assets?
- What is the all time high annual current assets for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual current assets year-on-year change?
- What is Aldeyra Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly current assets year-on-year change?
What is Aldeyra Therapeutics annual total current assets?
The current annual current assets of ALDX is $147.81 M
What is the all time high annual current assets for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total current assets is $232.75 M
What is Aldeyra Therapeutics annual current assets year-on-year change?
Over the past year, ALDX annual total current assets has changed by -$33.21 M (-18.35%)
What is Aldeyra Therapeutics quarterly total current assets?
The current quarterly current assets of ALDX is $116.72 M
What is the all time high quarterly current assets for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total current assets is $256.26 M
What is Aldeyra Therapeutics quarterly current assets year-on-year change?
Over the past year, ALDX quarterly total current assets has changed by -$30.49 M (-20.71%)